<SEC-DOCUMENT>0001171843-20-003680-index.html : 20200513 <SEC-HEADER>0001171843-20-003680.hdr.sgml : 20200513 <ACCEPTANCE-DATETIME>20200513161514 ACCESSION NUMBER: 0001171843-20-003680 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20200512 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 20873332 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>f8k_051320.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: f8k_051320.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.1 <SEQUENCE>2 <FILENAME>exh_31.htm <DESCRIPTION>EXHIBIT 3.1 <TEXT> Document 2 - file: exh_31.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-3.2 <SEQUENCE>3 <FILENAME>exh_32.htm <DESCRIPTION>EXHIBIT 3.2 <TEXT> Document 3 - file: exh_32.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>4 <FILENAME>exh_101.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 4 - file: exh_101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>5 <FILENAME>exh_102.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 5 - file: exh_102.htm
</DOCUMENT> </SEC-DOCUMENT>